| Released | Contributor | Author | Title | Pages | Price |
| 30-Nov-2009 | ValuEngine, Inc. |
N/A
| ValuEngine Industry Report for DRUGS | 18 |
$49 |
| 30-Nov-2009 | Wright Reports |
N/A
| Wright Investors Service Comprehensive Report for Anadys Pharmaceuticals, Inc. | 40 |
$65 |
| 30-Nov-2009 | ValuEngine, Inc. |
N/A
| ValuEngine Detailed Valuation Report for ANDS | 13 |
$25 |
| 28-Nov-2009 | Standard & Poor's Quantitative Report |
N/A
| Anadys Pharmaceuticals | 6 |
$25 |
| 27-Nov-2009 | Pechala's Reports | Lubomir Pechala | ANADYS PHARMACEUTICALS INC (ANDS=US) 2-weeks forecast | 1 |
$10 |
| 27-Nov-2009 | Pechala's Reports | Frantisek Pechala | ANADYS PHARMACEUTICALS INC (ANDS=US) 12-months forecast | 1 |
$15 |
| 27-Nov-2009 | Zacks Investment Research Inc. |
N/A
| ANADYS PHARMACT (ANDS) Zacks Company Snapshot | 1 |
$10 |
| 26-Nov-2009 | Ford Investor Services, Inc. |
N/A
| Value Graph: ANADYS PHARMACEU -- ANDS | 1 |
$4 |
| 26-Nov-2009 | Ford Investor Services, Inc. |
N/A
| Industry Value Graph: ACOR , AFFY , ANDS , BSTC , OMPI , TELK -- DRUGS | 3 |
$4 |
| 25-Nov-2009 | Zacks Investment Research Inc. |
N/A
| ANADYS PHARMACT (ANDS) Zacks Company Snapshot | 1 |
$10 |
0.34% Nasdaq 0.00%
Research Reports
